Immunovia invites you to a teleconference in connection with the publishing of the first half-year report for 2016. The conference call will take place at 10 a.m. on 24 August and the results will be published at around 8.30 a.m. the same day Immunovia invites you to a teleconference in connection with the publishing of the first half-year’s results for 2016. The conference call, which is expected to last for a maximum one hour, will be held in Swedish. After a presentation of the company by CEO Mats Grahn, you will have the opportunity to ask questions. Please dial in a few minutes before the conference call begins. Date: August 24, 2016 Time: 10:00 (CET) Phone numbers: SE: +46 8 566 426 62 CH: +41 225 675 548 DE: +49 692 222 290 46 UK: +44 203 008 98 04 On Immunovias website under Investors / Financial Reports (http://immunovia.com/investors/financial-reports/) there will be an MP3 file for anyone who wants to listen to the conference afterwards. The file will be available within 2 hours after the conference has ended. Half-year results are expected to be published at 08.30 a.m. (CET) on 24 August. For questions and interview appointments: ir@immunovia.com About Immunovia Immunovia AB was founded in 2007 by investigators from the Department of Immunotechnology at Lund University and CREATE Health, the Center for Translational Cancer Research in Lund, Sweden. Immunovia’s strategy is to decipher the wealth of information in blood and translate it into clinically useful tools to diagnose complex diseases such as cancer, earlier and more accurately than previously possible. Immunovia´s core technology platform, IMMray™, is based on antibody biomarker microarray analysis. The company is now performing clinical validation studies for the commercialization of IMMray™ PanCan-d that could be the first blood based test for early diagnosis of pancreatic cancer. In the beginning of 2016, the company started a program focused on autoimmune diseases diagnosis, prognosis and therapy monitoring. The first test from this program, IMMray™ SLE-d, is a biomarker signature derived for differential diagnosis of lupus, now undergoing evaluation and validation. (Source: www.immunovia.com) Immunovia’s shares (IMMNOV) are listed on Nasdaq First North in Stockholm and Wildeco is the company’s Certified Adviser. For more information, please visit www.immunovia.com. ###
Immunovia invitation to a teleconference on 24 August 2016
Top 10 Most Recent News Articles
IEHP's Wellness Center Launch Faces Delay in California
Unexpected Delay for IEHP's Community Hub Straight outta Rancho Cucamonga, we've got some news that'll have folks in San Bernardino holding their breath a little longer. The Inland Empire Health Plan (or IEHP if you're part of the 1.4 million served by them) had folks pumped for their new Community Wellness Center. But guess what? They had to slam the brakes on the grand...
Continue Reading
HONGQI's EHS4 Launch in Europe: Bridging East and West
Revving Up a New Chapter: HONGQI in Venice There's a new player in the European automotive scene, and it's rolling in with more style than a Venetian gondola. HONGQI, a name that's been turning gears in China since '58, is packing its suitcases full of Eastern elegance and landing straight in Venice with the all-electric EHS4. On November 16, the brand is set to unveil...
Continue Reading
EFICYENT Ventures to Connect at Singapore FinTech Fest
Why the Singapore FinTech Festival Matters The world's hardly a stranger to hype, but the Singapore FinTech Festival carries some real weight. From November 18 to 20, 2026, this gig isn't just industry chatter—it's a high-stakes convergence of policymakers, financial institutions, fintech innovators like EFICYENT, and the money folk looking to mold the future of...
Continue Reading
Novo's CagriSema Trial Shows Promising Obesity Results
Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...
Continue Reading
SmallRig Boosts Art-Driven Innovation in AI Era
The Interplay of Art and AI In a world where the lines between man and machine blur faster than ever, creators like SmallRig are boldly asking: what role should authenticity play when AI takes the stage? The Shenzhen International Art Museum and SmallRig stood shoulder to shoulder, tackling this head-scrambling question with a global gathering of art and tech giants. It's...
Continue Reading
Retirement Dreams Dashed: 61% Withdraw Early
Retirement Caught in the Crosshairs Just when you think the path to retirement might clear up, life slaps down older workers with economic reality. A recent LiveCareer survey underscores this financial mess, revealing that 61% of those 50 and older are raiding their own retirement funds to make ends meet. It's enough to make one's head spin. Inflation: The Unwanted Guest...
Continue Reading
WeaveGrid Powers EVConnectNC: Charging Incentives Launched
Transforming Utilities with EVConnectNC In a fresh move by WeaveGrid, North Carolina's Electric Cooperatives have teamed up to roll out EVConnectNC. This innovative program aims to manage the burgeoning demand for electric vehicle (EV) charging in rural and suburban areas under North Carolina's cooperative umbrella. Think of it as a smart way to handle new loads without...
Continue Reading
Advanta's Game-Changer: Acquiring Misr Hytech to Expand in Africa
Advanta's Strategic Move into Africa Alright, let's cut to the chase. Advanta is making a big splash with its acquisition of Misr Hytech, a move that's going to shake things up in Africa's agricultural sector. This isn't just another merger to gloss over with your morning coffee. We're talking about a deal that's supposed to wrap up by January 31, 2027, bringing together...
Continue Reading
AppLovin Legal Woes: A Deep Dive into Investor Claims
AppLovin Faces Legal Heat and Market Scrutiny Bitter truth has a way of crashing like a wave, and AppLovin (NASDAQ: APP) is feeling the brunt of it. Now knee-deep in a securities class action, the firm’s been accused of selling fairy tales about its AI capabilities, leaving investors clutching at substantial losses. If you’ve been banking on their promises between...
Continue Reading
Uber Data Breach: Class Action Investigation Begins
When Tech Meets Trouble: Uber's Data Breach Picture this: the hum of Uber rides weaving through your city, drivers none the wiser that personal info has been pried from the vaults thanks to their tech partner, Fireworks AI. Uber, folks, is in hot water once again. This isn’t just another tech hiccup; it's a legal whirlwind brewing up courtesy of Edelson Lechtzin LLP, a...
Continue ReadingTop 5 Most Recently Viewed Articles
XPENG Introduces Next-Gen P7 Sports Sedan with Dynamic Design
XPENG Unveils the All-New P7 Sports Sedan XPENG has recently captured the attention of the automotive industry by unveiling the first images of its next-generation P7 sports sedan, a stunning evolution of its well-respected electric vehicle. This latest model embodies a daring and emotionally resonant design, continuing the company's commitment to excellence in the...
Continue Reading
Millicom Enhances Shareholder Value Through Repurchase Program
Millicom's Share Repurchase Initiative Millicom, a leading telecommunications provider known for its dedication to enhancing shareholder value, recently launched a share repurchase program. This initiative, announced on a significant date, sets the stage for Millicom to strengthen its financial position and reward its investors more effectively. Details of the Share...
Continue Reading
TransformativeMed Embraces AI with Strategic Vantiq Alliance
TransformativeMed Forms Strategic Partnership with Vantiq TransformativeMed Now Positioned as Go-To Platform for Intelligent Systems and AI Leadership TransformativeMed, known for its exceptional CORES Platform, has established a strategic collaboration with Vantiq, a global leader in real-time AI and intelligent systems platforms. This partnership aims to position...
Continue Reading
Exciting Development Announced for The Row in Austin, Texas
The Row's Ambitious Next Steps The Row, an innovative mixed-use development, is on the brink of a transformative phase, focusing on enriching the far southeast area with vibrant retail, dining, and hotel options. This community-driven effort aims to elevate the quality of living for residents while creating a bustling hub for visitors. New Name, New Vision Previously...
Continue Reading
Exploring the Future of Carbon Capture and Storage Technologies
Introduction to Carbon Capture Technologies The carbon capture, utilization, and storage (CCUS) market offers an exciting glimpse into the future of energy sustainability. As the world increasingly confronts the challenges of climate change, new innovations in CCUS are becoming vital. Experts anticipate that this market will expand significantly, with projections...
Continue Reading